We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO

Product News   Jun 03, 2014

 
Nanobiotix Presents Successful Phase I Results for NBTXR3 at ASCO
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Phico Therapeutics Awarded Innovate UK Funding for £1.4 Million ($1.87M) Antibacterial Therapy Project

Product News

Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance.

READ MORE

Breast Cancer Device Receives FDA Approval

Product News

The first non-radioactive, dual-tracer for sentinel lymph node biopsy approved in the U.S.

READ MORE

Bio-Rad Announces the Launch of Anti-Ranibizumab Antibodies

Product News

Ranibizumab is used for the treatment of wet age-related macular degeneration (AMD).

READ MORE

Like what you just read? You can find similar content on the communities below.

Applied Sciences Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE